Clinuvel Pharmaceuticals Aktie
Clinuvel Pharmaceuticals-Aktie
WKN: A0JEGY
ISIN: AU000000CUV3
Land: Australien
Branche: Chemie, Pharma, Bio- & Medizintechnik
Sektor: Pharma
5,88 EUR -0,07  EUR -1,22  %
23:00:05 L&S RT
boerse.de-
Aktien-
Rating:

(Info)
B
Neu

Weshalb die Clinuvel Pharmaceuticals-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 10. März 2026 Info.

Komplette Navigation anzeigen

Statistik Clinuvel Pharmaceuticals seit 01.09.2004

Clinuvel Pharmaceuticals Aktie: Die besten Jahre

Rang Datum Vorjahr Schluss Performance
1 2014 0,6400 2,7300 326,56%
2 2016 1,8000 4,9800 176,67%
3 2006 2,1100 4,5000 113,27%
4 2018 5,3900 10,9000 102,23%
5 2019 10,9000 17,9000 64,22%
6 2009 1,2000 1,8700 55,83%
7 2012 1,1800 1,5800 33,90%
8 2021 13,9300 18,3000 31,37%
9 2017 4,9800 5,3900 8,23%
10 2025 7,1500 7,0000 -2,10%
11 2010 1,8700 1,6700 -10,70%
12 2026 7,0000 5,9100 -15,57%
13 2020 17,9000 13,9300 -22,18%
14 2022 18,3000 13,5300 -26,07%
15 2023 13,5300 9,9200 -26,68%
16 2024 9,9200 7,1500 -27,92%
17 2011 1,6700 1,1800 -29,34%
18 2015 2,7300 1,8000 -34,07%
19 2008 2,1000 1,2000 -42,86%
20 2007 4,5000 2,1000 -53,33%

Clinuvel Pharmaceuticals Aktie: Die schlechtesten Jahre

Rang Datum Vorjahr Schluss Performance
1 2013 1,5800 0,6400 -59,49%
2 2005 5,1700 2,1100 -59,19%
3 2007 4,5000 2,1000 -53,33%
4 2008 2,1000 1,2000 -42,86%
5 2015 2,7300 1,8000 -34,07%
6 2011 1,6700 1,1800 -29,34%
7 2024 9,9200 7,1500 -27,92%
8 2023 13,5300 9,9200 -26,68%
9 2022 18,3000 13,5300 -26,07%
10 2020 17,9000 13,9300 -22,18%
11 2026 7,0000 5,9100 -15,57%
12 2010 1,8700 1,6700 -10,70%
13 2025 7,1500 7,0000 -2,10%
14 2017 4,9800 5,3900 8,23%
15 2021 13,9300 18,3000 31,37%
16 2012 1,1800 1,5800 33,90%
17 2009 1,2000 1,8700 55,83%
18 2019 10,9000 17,9000 64,22%
19 2018 5,3900 10,9000 102,23%
20 2006 2,1100 4,5000 113,27%